Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Plant-derived bioactive compounds in colon cancer treatment: An updated review
Akanksha Esmeeta, Subhamay Adhikary, V. Dharshnaa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113384-113384
Open Access | Times Cited: 159
Programmed Cell Death in Health and Disease
Lara Gibellini, Loredana Moro
Cells (2021) Vol. 10, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 60
Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
Si-Xia Wu, Ruo-Gu Xiong, Siyu Huang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 33, pp. 12422-12440
Closed Access | Times Cited: 53
Natural Phytochemicals in Bladder Cancer Prevention and Therapy
Yong Xia, Ruijiao Chen, Guangzhen Lu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistance
Yu Liying, Na Lin, Yan Ye, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1734-1749
Open Access | Times Cited: 3
[6]-Shogaol Induces Apoptosis of Murine Bladder Cancer Cells
Diana Gabriela Nina Nina, Thaiane Robeldo, James Almada da Silva, et al.
Cellular Physiology and Biochemistry (2024) Vol. 58, Iss. 1, pp. 49-62
Open Access | Times Cited: 2
A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System
Xinming Zhao, Xiaochen Qi, Dequan Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13461-13483
Open Access | Times Cited: 2
Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer
Xiangli He, Jiayan Cui, Hui Ma, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115868-115868
Closed Access | Times Cited: 6
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward
Andreia Bilé-Silva, Antonio López-Beltrán, Ana Blanca, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 5, pp. 407-418
Closed Access | Times Cited: 5
Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
Meng Zhang, Junlong Zhu, Pan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway
A Janev, Taja Železnik Ramuta, Urška Dragin Jerman, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Light-triggered polymeric prodrug and nano-assembly for chemo-photodynamic therapy and potentiate immune checkpoint blockade immunotherapy for hepatocellular carcinoma
Yang Gao, Zhe Su, Cui Wang, et al.
Materials & Design (2022) Vol. 225, pp. 111457-111457
Open Access | Times Cited: 9
Tripartite motif–containing 9 promoted proliferation and migration of bladder cancer cells through CEACAM6-Smad2/3 axis
Zhaocun Zhang, Haifeng Zhao, Zhuang Sun, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1323-1333
Open Access | Times Cited: 4
Mechanism Study on Radiosensitization Effect of Curcumin in Bladder Cancer Cells Regulated by Filamin A
Zhenfan Wang, Shuqing He, Minjun Jiang, et al.
Dose-Response (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 6
Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery
Yoo Goo Kang, Chelin Park, Heemin Lee, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1117-1117
Open Access | Times Cited: 3
Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B
Wenpeng Cao, Xiaozong Chen, Chaolun Xiao, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9377-9390
Open Access | Times Cited: 3
Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer
Shi‐Shuo Wang, Gao‐Qiang Zhai, Gang Chen, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153847-153847
Closed Access | Times Cited: 4
Physicochemical Features and Applicability of Newly Fabricated Phytopharmaceutical‐Loaded Hydrogel Alginate Microcarriers with Viscoelastic Polyelectrolyte Coatings
Weronika Szczęsna‐Górniak, Joanna Weżgowiec, Marta Tsirigotis‐Maniecka, et al.
ChemPhysChem (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 1
Role of Pentacyclic Triterpenoid Acids in the Treatment of Bladder Cancer
Anindita Ghosh, Chinmay Kumar Panda
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 9, pp. 1331-1340
Closed Access | Times Cited: 3
Evaluating the Anticancer Activity of Natural Products Using a Novel 3D Culture Model
Chloe Shay, Yong Teng
Methods in molecular biology (2021), pp. 159-164
Closed Access | Times Cited: 1
Page 1

Scroll to top